Cargando…
Efficacy and safety of Shenyankangfu tablets for primary glomerulonephritis: study protocol for a randomized controlled trial
BACKGROUND: Chronic kidney disease is a common disease. Most chronic kidney diseases evolve from primary glomerulonephritis. Proteinuria is an independent risk factor for the progression of chronic kidney disease. The general consensus is that therapy administered to decrease proteinuria should incl...
Autores principales: | Kou, Jia, Wu, Jie, Yang, Hong-tao, He, Ya-ni, Fang, Jing-ai, Deng, Yue-yi, Xie, Yuan-sheng, Nie, Li-fang, Lin, Hong-li, Cai, Guang-yan, Chen, Xiang-mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289030/ https://www.ncbi.nlm.nih.gov/pubmed/25480673 http://dx.doi.org/10.1186/1745-6215-15-479 |
Ejemplares similares
-
Meta-analysis of the effectiveness and safety of Shenyankangfu tablets combined with losartan potassium in the treatment of chronic glomerulonephritis
por: Feng, Pan-Feng, et al.
Publicado: (2022) -
Exploring the Underlying Mechanism of Shenyankangfu Tablet in the Treatment of Glomerulonephritis Through Network Pharmacology, Machine Learning, Molecular Docking, and Experimental Validation
por: Jin, Meiling, et al.
Publicado: (2021) -
The efficacy and safety of Fufangdanshen tablets (Radix Salviae miltiorrhizae formula tablets) for mild to moderate vascular dementia: a study protocol for a randomized controlled trial
por: Tian, Jinzhou, et al.
Publicado: (2016) -
Efficacy and safety of Bujing Yishi tablet for glaucoma with controlled IOP: study protocol for a multi-centre randomized controlled trial
por: Liu, Hongji, et al.
Publicado: (2020) -
The efficacy and safety of the Shaoyao Shujin tablet for knee osteoarthritis: study protocol for a randomized controlled trial
por: Cao, Xue-Wei, et al.
Publicado: (2016)